Literature DB >> 29255955

Splenic Artery Pseudoaneurysm.

Aires Martins1,2, Álvaro Gonçalves3, Paulo Passos3, Marília Cardoso3, Rui Torres3, Teresa Almeida3, Alberto Midões3.   

Abstract

Splenic artery pseudoaneurysm is an extremely rare entity, although it is the most frequent location of visceral pseudoaneurysms. Trauma or previous pancreatitis (where the proteolytic pancreatic enzymes lead to the formation of pseudoaneurysm, as a result of enzymatic injury to the splenic artery wall) (Amico and Alves in Pancreatology 14: 144-145, 2014) is the most frequent causes. A high degree of suspicion is required for the accurate diagnosis. The authors present a case of splenic artery pseudoaneurysm in a middle-aged man who came to the emergency department with several days of abdominal pain.

Entities:  

Keywords:  Pseudoaneurysm; Splenic artery; Total splenectomy

Mesh:

Year:  2017        PMID: 29255955     DOI: 10.1007/s11605-017-3643-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  2 in total

1.  Rupture of splenic artery pseudoaneurysm.

Authors:  Enio Campos Amico; José Roberto Alves
Journal:  Pancreatology       Date:  2014 Mar-Apr       Impact factor: 3.996

2.  Idiopathic Splenic Artery Pseudoaneurysm Rupture as an Uncommon Cause of Hemorrhagic Shock.

Authors:  Richard A Schatz; Stephen Schabel; Don C Rockey
Journal:  J Investig Med High Impact Case Rep       Date:  2015-04-13
  2 in total
  2 in total

1.  Imaging-Guided Percutaneous Puncture and Embolization of Visceral Pseudoaneurysms: Feasibility and Outcomes.

Authors:  Serena Carriero; Carolina Lanza; Pierpaolo Biondetti; Matteo Renzulli; Cristian Bonelli; Filippo Piacentino; Federico Fontana; Massimo Venturini; Gianpaolo Carrafiello; Anna Maria Ierardi
Journal:  J Clin Med       Date:  2022-05-24       Impact factor: 4.964

2.  Application of interventional embolization in the treatment of iatrogenic pseudoaneurysms.

Authors:  Hao Xu; Cong Jing; Jie Zhou; Xuli Min; Jing Zhao; Lin Yang; Yongjun Ren
Journal:  Exp Ther Med       Date:  2020-10-22       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.